. Che-clinique, AOM 06060 and AOM 08209) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

L. Andreoletti, T. Blanchon, F. Carrat, X. Duval, A. Guimfack et al., Invited members (informed of study design but did not participate in any decision-making study discussions Independent data-monitoring committee (advice on trial conduct and interruption Monitoring and statistical analysis Studypharm clinical research organizations Clinical investigators (responsible for patient enrollment and follow-up ) References 1 Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis, Lancet Infect Dis, vol.9, pp.537-545, 2009.

T. Jefferson, M. Jones, P. Doshi, D. Mar, C. Dooley et al., Neuraminidase inhibitors for preventing and treating influenza in healthy adults, Cochrane Database Syst Rev, vol.2, p.1265, 2010.

M. Shun-shin, M. Thompson, C. Heneghan, R. Perera, A. Harnden et al., Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials, BMJ, vol.339, issue.aug10 1, p.3172, 2009.
DOI : 10.1136/bmj.b3172

F. Hayden, A. Osterhaus, and J. Treanor, Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections, New England Journal of Medicine, vol.337, issue.13, pp.874-880, 1997.
DOI : 10.1056/NEJM199709253371302

K. Nicholson, F. Aoki, and A. Osterhaus, Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial, The Lancet, vol.355, issue.9218, pp.1845-1850, 2000.
DOI : 10.1016/S0140-6736(00)02288-1

J. Treanor, F. Hayden, and P. Vrooman, Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza, JAMA, vol.283, issue.8, pp.1016-1024, 2000.
DOI : 10.1001/jama.283.8.1016

N. Kawai, H. Ikematsu, and N. Iwaki, Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza Season, Clinical Infectious Diseases, vol.40, issue.9, pp.1309-1316, 2005.
DOI : 10.1086/429241

N. Kawai, H. Ikematsu, and N. Hirotsu, Clinical Effectiveness of Oseltamivir and Zanamivir for Treatment of Influenza A Virus Subtype H1N1 with the H274Y Mutation: A Japanese, Multicenter Study of the 2007???2008 and 2008???2009 Influenza Seasons, Clinical Infectious Diseases, vol.49, issue.12, pp.1828-1835, 2007.
DOI : 10.1086/648424

F. Aoki, M. Macleod, and P. Paggiaro, Early administration of oral oseltamivir increases the benefits of influenza treatment, Journal of Antimicrobial Chemotherapy, vol.51, issue.1, pp.123-129, 2003.
DOI : 10.1093/jac/dkg007

Y. Matsuzaki, K. Mizuta, and Y. Aoki, A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir, Virology Journal, vol.7, issue.1, p.53, 2010.
DOI : 10.1186/1743-422X-7-53

N. Sugaya, K. Mitamura, and M. Yamazaki, Lower Clinical Effectiveness of Oseltamivir against Influenza B Contrasted with Influenza A Infection in Children, Clinical Infectious Diseases, vol.44, issue.2, pp.197-202, 2007.
DOI : 10.1086/509925

X. Duval, S. Van-der-werf, and T. Blanchon, Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial, PLoS Medicine, vol.48, issue.11, p.1000362, 2010.
DOI : 10.1371/journal.pmed.1000362.s006

URL : https://hal.archives-ouvertes.fr/inserm-00701161

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-1496, 2002.
DOI : 10.1016/S0277-9536(01)00125-3

B. Stuart, L. Simoni-wastila, and I. Zuckerman, Impact of maintenance therapy on hospitalization and expenditures for medicare beneficiaries with chronic obstructive pulmonary disease, The American Journal of Geriatric Pharmacotherapy, vol.8, issue.5, pp.441-453, 2010.
DOI : 10.1016/j.amjopharm.2010.10.002

J. Bates, R. Whitehead, S. Bolge, and E. Kim, Correlates of Medication Adherence Among Patients With Bipolar Disorder, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.12, 2010.
DOI : 10.4088/PCC.09m00883yel

U. Kirchmayer, N. Agabiti, and V. Belleudi, Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy, Journal of Clinical Pharmacy and Therapeutics, vol.21, issue.7, 2011.
DOI : 10.1111/j.1365-2710.2010.01242.x

B. Borah, P. Sacco, and V. Zarotsky, Predictors of adherence among Alzheimer's disease patients receiving oral therapy, Current Medical Research and Opinion, vol.26, issue.8, pp.1-957, 2010.
DOI : 10.1185/03007995.2010.493788

I. Mulazzi, J. Cambou, X. Girerd, R. Nicodeme, B. Chamontin et al., Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice, Journal of the American Society of Hypertension, vol.3, issue.3, pp.221-227, 2009.
DOI : 10.1016/j.jash.2008.12.004

R. Mo, J. Chen, A. Grolleau-julius, H. Murphy, B. Richardson et al., Estrogen Regulates CCR Gene Expression and Function in T Lymphocytes, The Journal of Immunology, vol.174, issue.10, pp.6023-6029, 2005.
DOI : 10.4049/jimmunol.174.10.6023

A. Roden, M. Moser, and S. Tri, Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation, The Journal of Immunology, vol.173, issue.10, pp.6098-6108, 2004.
DOI : 10.4049/jimmunol.173.10.6098

G. He, J. Massarella, and P. Ward, Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802, Clinical Pharmacokinetics, vol.37, issue.6, pp.471-484, 1999.
DOI : 10.2165/00003088-199937060-00003

J. Schwartz, The Influence of Sex on Pharmacokinetics, Clinical Pharmacokinetics, vol.68, issue.5, pp.107-121, 2003.
DOI : 10.2165/00003088-200342020-00001

J. Lin, M. Chiba, I. Chen, J. Nishime, and K. Vastag, Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence, Drug Metab Dispos, vol.24, pp.1298-1306, 1996.

A. Barsky, H. Peekna, and J. Borus, Somatic symptom reporting in women and men, Journal of General Internal Medicine, vol.330, issue.4, pp.266-275, 2001.
DOI : 10.1046/j.1525-1497.2001.016004266.x

E. Suzuki and K. Ichihara, The course of fever following influenza virus infection in children treated with oseltamivir, Journal of Medical Virology, vol.20, issue.6, pp.1065-1071, 2008.
DOI : 10.1002/jmv.21144

N. Kawai, N. Iwaki, and T. Kawashima, Effectiveness of Oseltamivir on Influenza and Influencing Factors, Journal of the Japanese Association for Infectious Diseases, vol.77, issue.6, pp.423-429, 2003.
DOI : 10.11150/kansenshogakuzasshi1970.77.423

S. Heinonen, H. Silvennoinen, and P. Lehtinen, Early Oseltamivir Treatment of Influenza in Children 1???3 Years of Age: A Randomized Controlled Trial, Clinical Infectious Diseases, vol.51, issue.8, pp.887-894, 2010.
DOI : 10.1086/656408

N. Lee, P. Chan, and K. Choi, Factors associated with early hospital discharge of adult influenza patients, Antivir Ther, vol.12, pp.501-508, 2007.